{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:32:40Z","timestamp":1772580760630,"version":"3.50.1"},"reference-count":21,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>To date, all the familial hyperaldosteronism type III (FH-III) patients reported presenting with typical primary aldosteronism (PA), without showing other adrenal hormone abnormalities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>This study characterized a novel phenotype of FH-III and explored the possible pathogenesis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients and Methods:<\/jats:title>\n                  <jats:p>A male patient presented with severe hypertension and hypokalemia at the age of 2 years and developed Cushing\u2019s syndrome at 20 years. He was diagnosed with PA and Cushing\u2019s syndrome on the basis of typical biochemical findings. He had massive bilateral adrenal hyperplasia and underwent left adrenalectomy. KCNJ5 was sequenced, and secretion of aldosterone and cortisol were observed both in vivo and in vitro.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>A heterozygous germline p.Glu145Gln mutation of KCNJ5 was identified. ARMC5, PRKAR1A, PDE8B, PDE11A, and PRKACA genes and \u03b2-catenin, P53 immunoactivity were normal in the adrenal. CYP11B2 was highly expressed, whereas mRNA expression of CYP11B1, CYP17A1, and STAR was relatively low in the hyperplastic adrenal, compared with normal adrenal cortex and other adrenal diseases. In the primary cell culture of the resected hyperplastic adrenal, verapamil and nifedipine, two calcium channel blockers, markedly inhibited the secretion of both aldosterone and cortisol and the mRNA expression of CYP11B1, CYP11B2, CYP17A1, and STAR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>We presented the first FH-III patient who had both severe PA and Cushing\u2019s syndrome. Hypersecretion of cortisol might be ascribed to overly large size of the hyperplastic adrenal because CYP11B1 expression was relatively low in his adrenal. Like aldosterone, synthesis and secretion of cortisol in the mutant adrenal may be mediated by voltage-gated Ca2+ channels.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2016-1504","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T19:08:43Z","timestamp":1468350523000},"page":"4290-4297","source":"Crossref","is-referenced-by-count":30,"title":["A Novel Phenotype of Familial Hyperaldosteronism Type III: Concurrence of Aldosteronism and Cushing\u2019s Syndrome"],"prefix":"10.1210","volume":"101","author":[{"given":"Anli","family":"Tong","sequence":"first","affiliation":[{"name":"Department of Endocrinology (A.T., F.W.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghua","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Endocrinology, Ministry of Health, and Departments of Urology (G.L., Y.Z.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (A.T., F.W.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Key Laboratory of Genome Sciences and Information (J.J.), Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoli","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (Z.Y.), Affiliated Hospital of the Inner Mongolia Medical University, Hohhot 010050, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianxi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical Laboratory (D.Z.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinsheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Endocrinology, Ministry of Health, and Departments of Urology (G.L., Y.Z.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[{"name":"Hypertension Center (J.C.), Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"key":"2020071616562615000_B1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1055\/s-0035-1564166","article-title":"An update on familial hyperaldosteronism","volume":"47","author":"Korah","year":"2015","journal-title":"Horm Metab Res"},{"key":"2020071616562615000_B2","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1210\/jc.2014-3636","article-title":"A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue","volume":"100","author":"Monticone","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616562615000_B3","doi-asserted-by":"crossref","first-page":"E1861","DOI":"10.1210\/jc.2013-2428","article-title":"a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III","volume":"98","author":"Monticone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616562615000_B4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"key":"2020071616562615000_B5","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071616562615000_B6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000358197","article-title":"Discordant genotype-phenotype correlation in familial hyperaldosteronism type III with KCNJ5 gene mutation: a patient report and review of the literature","volume":"82","author":"Adachi","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"2020071616562615000_B7","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616562615000_B8","doi-asserted-by":"crossref","first-page":"E1532","DOI":"10.1210\/jc.2012-1334","article-title":"A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension","volume":"97","author":"Charmandari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616562615000_B9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1507\/endocrj.EJ11-0406","article-title":"Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mussa","year":"2012","journal-title":"Endocr J"},{"key":"2020071616562615000_B10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"2020071616562615000_B11","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.4076\/1757-1626-2-8951","article-title":"Adrenocortical carcinoma secreting cortisol, androgens and aldosterone: a case report","volume":"2","author":"Peppa","year":"2009","journal-title":"Cases J"},{"key":"2020071616562615000_B12","first-page":"67","article-title":"Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma","volume":"62","author":"Kurtulmus","year":"2004","journal-title":"Horm Res"},{"key":"2020071616562615000_B13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EJE-10-1070","article-title":"Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism","volume":"164","author":"Spath","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2020071616562615000_B14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ12-0247","article-title":"KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas","volume":"59","author":"Yamada","year":"2012","journal-title":"Endocr J"},{"key":"2020071616562615000_B15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/hr.2010.18","article-title":"Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism","volume":"33","author":"Willenberg","year":"2010","journal-title":"Hypertens Res"},{"key":"2020071616562615000_B16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2014.05.002","article-title":"Adrenal CYP11B1\/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies","volume":"392","author":"Nakamura","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2020071616562615000_B17","doi-asserted-by":"crossref","first-page":"R249","DOI":"10.1530\/EJE-15-1118","article-title":"Endocrine tumours: the genomics of adrenocortical tumors","volume":"174","author":"Faillot","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2020071616562615000_B18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1530\/eje.1.02011","article-title":"Shift from Conn\u2019s syndrome to Cushing\u2019s syndrome in a recurrent adrenocortical carcinoma","volume":"153","author":"Barzon","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2020071616562615000_B19","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1210\/jc.2010-1885","article-title":"Wnt\/\u03b2-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors","volume":"96","author":"Bonnet","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616562615000_B20","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/en.2013-1944","article-title":"Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas","volume":"155","author":"Tauber","year":"2014","journal-title":"Endocrinology"},{"key":"2020071616562615000_B21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0083-6729(05)70008-X","article-title":"Biochemical and Ionic signaling mechanisms for ACTH-stimulated cortisol production","volume":"70","author":"Enyeart","year":"2005","journal-title":"Vitam Horm"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/11\/4290\/10529951\/jcem4290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/11\/4290\/10529951\/jcem4290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:27:13Z","timestamp":1594956433000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/11\/4290\/2765006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,12]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-1504","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,12]]}}}